BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35127253)

  • 1. Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells.
    Serrano R; Lettau M; Zarobkiewicz M; Wesch D; Peters C; Kabelitz D
    Oncoimmunology; 2022; 11(1):2030021. PubMed ID: 35127253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes.
    Serrano R; Wesch D; Kabelitz D
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands.
    Serrano R; Coch C; Peters C; Hartmann G; Wesch D; Kabelitz D
    Sci Rep; 2021 Jul; 11(1):15231. PubMed ID: 34315922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal strength of STING activation determines cytokine plasticity and cell death in human monocytes.
    Kabelitz D; Zarobkiewicz M; Heib M; Serrano R; Kunz M; Chitadze G; Adam D; Peters C
    Sci Rep; 2022 Oct; 12(1):17827. PubMed ID: 36280676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity.
    Poonia B; Pauza CD
    Cytotherapy; 2012 Feb; 14(2):173-81. PubMed ID: 22029653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronate promotes inflammatory cytokine expression in human CD14-positive monocytes among peripheral mononuclear cells in the presence of γδ T cells.
    Takimoto R; Suzawa T; Yamada A; Sasa K; Miyamoto Y; Yoshimura K; Sasama Y; Tanaka M; Kinoshita M; Ikezaki K; Ichikawa M; Yamamoto M; Shirota T; Kamijo R
    Immunology; 2021 Mar; 162(3):306-313. PubMed ID: 33131052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 conditioning of peripheral blood mononuclear cells from breast cancer patients promotes the zoledronate-induced expansion of γδ T cells in vitro and enhances their cytotoxic activity and cytokine production.
    Assy L; Khalil SM; Attia M; Salem ML
    Int Immunopharmacol; 2023 Jan; 114():109402. PubMed ID: 36481526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PD1 does not improve pyroptosis induced by γδ T cells but promotes tumor regression in a pleural mesothelioma mouse model.
    Lui KS; Ye Z; Chan HC; Tanaka Y; Cheung AKL
    Front Immunol; 2023; 14():1282710. PubMed ID: 38077396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
    J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γδ T cells cultured with artificial antigen-presenting cells and IL-2 show long-term proliferation and enhanced effector functions compared with γδ T cells cultured with only IL-2 after stimulation with zoledronic acid.
    Choi H; Lee Y; Hur G; Lee SE; Cho HI; Sohn HJ; Cho BS; Kim HJ; Kim TG
    Cytotherapy; 2021 Oct; 23(10):908-917. PubMed ID: 34312069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin C promotes the proliferation and effector functions of human γδ T cells.
    Kouakanou L; Xu Y; Peters C; He J; Wu Y; Yin Z; Kabelitz D
    Cell Mol Immunol; 2020 May; 17(5):462-473. PubMed ID: 31171862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra.
    Tsukaguchi K; de Lange B; Boom WH
    Cell Immunol; 1999 May; 194(1):12-20. PubMed ID: 10357876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands.
    Choi H; Lee Y; Park SA; Lee JH; Park J; Park JH; Lee HK; Kim TG; Jeun SS; Ahn S
    Oncoimmunology; 2022; 11(1):2138152. PubMed ID: 36338147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and expansion of pure and functional γδ T cells.
    Verkerk T; Pappot AT; Jorritsma T; King LA; Duurland MC; Spaapen RM; van Ham SM
    Front Immunol; 2024; 15():1336870. PubMed ID: 38426099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2.
    Li W; Kubo S; Okuda A; Yamamoto H; Ueda H; Tanaka T; Nakamura H; Yamanishi H; Terada N; Okamura H
    J Immunother; 2010 Apr; 33(3):287-96. PubMed ID: 20445349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
    Story JY; Zoine JT; Burnham RE; Hamilton JAG; Spencer HT; Doering CB; Raikar SS
    Cytotherapy; 2021 Jan; 23(1):12-24. PubMed ID: 33168453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
    Knight A; Mackinnon S; Lowdell MW
    Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Activation of the STING-TBK1 Pathway in γδ T Cells Regulates Immune Responses in Oral Lichen Planus.
    Huang S; Tan YQ; Zhou G
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient 40 °C-shock potentiates cytotoxic responses of Vδ2
    Lin L; Chen Y; Chen D; Shu J; Hu Y; Yin Z; Wu Y
    Cancer Immunol Immunother; 2022 Oct; 71(10):2391-2404. PubMed ID: 35195762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.